The effect of venous thromboembolism on survival of cancer patients and its relationship with serum level of factor VIII and vascular endothelial growth factor: A prospective matched-paired study

International Journal of Biological Markers

Volumn 21, Issue 4, 2006, Pages 206-210

  Dogan, M ^a   Demirkazik, A ^a   Konuk, N ^a   Yalcin, Bulent ^a   Buyukcelik, A ^a   Utkan, G ^a   Tek, I ^a   Akbulut, H ^a   Sencan, O ^a   Icli, F ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cancer; Coagulation; Factor VIII; Vascular endothelial growth factor; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 8; D DIMER; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; PERFORMANCE; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM;

EID: 33846483859     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4592     Document Type: Article

References (21)

1. Harada Y, Ogata Y, Shirouzu K. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. Int J Clin Oncol 2001; 6: 221-8.
2. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 172-203.
3. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:,4-6.
4. Folkman J, Watson K, Ingbher D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-9.
5. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
6. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240-5.
7. Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211-20.
8. Ellis LM. Preclinical data targeting vascular endothelial growth factor incolorectal cancer. Clin Colorectal Cancer 2004; 4: 55-61.
9. Li M, Yang H, Chai H, et al. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 2004; 101: 2341-50.
10. Chelouche-Lev D, Miller CP, Tellez C, et al. Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy. Eur J Cancer 2004; 40: 2509-18.
11. Tanno S, Ohsaki Y, Nakanishi K, et al. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 2004; 46: 11-9.
12. Kaya A, Ciledag A, Gulbay BE, et al. The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respir Med 2004; 98: 632-6.
13. Hoar FJ, Lip GY, Belgore F, Stonelake PS. Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFlt-1) in human breast cancer. Int J Biol Markers 2004; 19: 229-35.
14. Piccioli A, Prandoni P, Goldhaber SZ. Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT Registry. Am Heart J 1996; 132: 1010-4.
15. Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50.
16. Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 2000; 90: 3167-72.
17. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 43: 457-62.
18. Eroglu A, Demirci S, Ayyildiz A, et al. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer Br J Cancer 1999: 80; 1630-4.
19. Spence GM, Graham AN, Mulholland K, et al. Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection - relationship to platelet count. Int J Biol Markers 2002; 17: 119-24.
20. Cox G, Jones JL, Walker RA, et al. Angiogenesis and non small cell cancer. Lung Cancer 2000; 27: 81-100.
21. Akbulut H, Altuntas F, Akbulut KG, et al. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine 2002; 20: 184-90.